JANUX THERAPEUTICS INC (JANX) Stock Earnings Estimates
NASDAQ:JANX • US47103J1051
13.08 USD
-0.34 (-2.53%)
At close: Feb 20, 2026
13.03 USD
-0.05 (-0.38%)
After Hours: 2/20/2026, 8:00:01 PM
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 8.61M 136.54% | 8.083M -6.12% | 10.588M 30.99% | 10.26M -3.10% | 1.434M -86.02% | 5.252M 266.25% | 42.682M 712.68% | 101.46M 137.71% | 375.44M 270.04% | 783.33M 108.64% | 1.291B 64.81% | 1.805B 39.81% | |
| EBITDA YoY % growth | -66.25M -101.86% | -71.024M -7.21% | -96.787M -36.27% | -162.682M -68.08% | -218.767M -34.47% | -266.713M -21.92% | -252.97M 5.15% | -250.787M 0.86% | -16.901M 93.26% | 251.73M 1,589.40% | 350.39M 39.19% | 436.92M 24.70% | |
| EBIT YoY % growth | -67.09M -103.74% | -72.979M -8.78% | -98.847M -35.45% | -167.63M -69.59% | -226.826M -35.31% | -282.82M -24.69% | -289.571M -2.39% | -309.879M -7.01% | -144.804M 53.27% | 151.73M 204.78% | 541.83M 257.10% | 1.037B 91.39% | |
| Operating Margin | -779.21% | -902.87% | -933.58% | -1,633.82% | -15,817.69% | -5,385.00% | -678.44% | -305.42% | -38.57% | 19.37% | 41.97% | 57.45% | |
| EPS YoY % growth | -1.52 -19.43% | -1.34 11.84% | -1.28 4.48% | -2.04 -59.34% | -2.97 -45.38% | -3.81 -28.38% | -4.03 -5.80% | -4.11 -2.13% | -1.42 65.50% | 1.64 215.83% | 5.85 256.04% | 10.26 75.35% |
All data in USD
| Q4 / 25 | Q1 / 26 | Q2 / 26 | Q3 / 26 | Q4 / 26 | Q1 / 27 | Q2 / 27 | Q3 / 27 | Q4 / 27 | |
|---|---|---|---|---|---|---|---|---|---|
| EPS Q2Q % growth | -0.66 -82.52% | -0.69 -80.52% | -0.75 -36.62% | -0.76 -95.59% | -0.82 -24.62% | -0.70 -1.85% | -0.74 0.91% | -0.81 -5.64% | -0.88 -7.75% |
| Revenue Q2Q % growth | 170.003K | 824.497K | 186.997K | 195.503K -98.04% | 195.503K 15.00% | -100.00% | -100.00% | -100.00% | -100.00% |
| EBITDA Q2Q % growth | -47.18M -74.99% | -48.96M -42.42% | -49.98M -13.44% | -51M -51.38% | -52.459M -11.19% | -55.08M -12.50% | -57.14M -14.33% | -58.283M -14.28% | -59.446M -13.32% |
| EBIT Q2Q % growth | -49.303M -69.88% | -41.305M -18.36% | -44.131M 2.19% | -45.555M -29.23% | -56.985M -15.58% | -55.08M -33.35% | -56.182M -27.31% | -47.104M -3.40% | -58.456M -2.58% |
All data in USD
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q3 2025 Q2Q % growth | -0.39 23.53% | -0.63 | 0.24 | 38.06% |
| Q2 2025 Q2Q % growth | -0.55 -400.00% | -0.48 | -0.07 | -15.55% |
| Q1 2025 Q2Q % growth | -0.38 -26.67% | -0.40 | 0.02 | 5.55% |
| Q4 2024 Q2Q % growth | -0.36 -44.00% | -0.46 | 0.10 | 22.57% |
| Q3 2024 Q2Q % growth | -0.51 -104.00% | -0.33 | -0.18 | -52.65% |
| Q2 2024 Q2Q % growth | -0.11 73.81% | -0.32 | 0.21 | 65.71% |
| Q1 2024 Q2Q % growth | -0.30 28.57% | -0.34 | 0.04 | 11.21% |
| Q4 2023 Q2Q % growth | -0.25 35.90% | -0.40 | 0.15 | 37.59% |
| Q3 2023 Q2Q % growth | -0.25 37.50% | -0.48 | 0.23 | 47.85% |
| Q2 2023 Q2Q % growth | -0.42 -2.44% | -0.53 | 0.11 | 20.43% |
| Q1 2023 Q2Q % growth | -0.42 -31.25% | -0.50 | 0.08 | 16.27% |
| Q4 2022 Q2Q % growth | -0.39 -18.18% | -0.50 | 0.11 | 21.41% |
| Q3 2022 Q2Q % growth | -0.40 -53.85% | -0.50 | 0.10 | 19.47% |
| Q2 2022 Q2Q % growth | -0.41 33.87% | -0.38 | -0.03 | -8.25% |
| Q1 2022 Q2Q % growth | -0.32 | -0.38 | 0.06 | 14.75% |
| Q4 2021 Q2Q % growth | -0.33 | -0.31 | -0.02 | -5.27% |
| Q3 2021 Q2Q % growth | -0.26 | -0.18 | -0.08 | -44.28% |
| Q2 2021 Q2Q % growth | -0.62 | -0.13 | -0.49 | -367.57% |
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q3 2025 Q2Q % growth | 10M 2,177.90% | 2.987M | 7.013M | 234.78% |
| Q2 2025 Q2Q % growth | -100.00% | 102K | -102K | -100.00% |
| Q1 2025 Q2Q % growth | -100.00% | 573.75K | -573.75K | -100.00% |
| Q4 2024 Q2Q % growth | -100.00% | 456.215K | -456.215K | -100.00% |
| Q3 2024 Q2Q % growth | 439K -82.56% | 1.674M | -1.235M | -73.78% |
| Q2 2024 Q2Q % growth | 8.897M 741.72% | 782.789K | 8.114M | 1,036.58% |
| Q1 2024 Q2Q % growth | 1.252M -38.87% | 778.648K | 473.352K | 60.79% |
| Q4 2023 Q2Q % growth | 2.461M -13.65% | 754.035K | 1.707M | 226.38% |
| Q3 2023 Q2Q % growth | 2.517M 39.06% | 862.41K | 1.655M | 191.86% |
| Q2 2023 Q2Q % growth | 1.057M -55.40% | 892.5K | 164.5K | 18.43% |
| Q1 2023 Q2Q % growth | 2.048M 28.81% | 685.695K | 1.362M | 198.68% |
| Q4 2022 Q2Q % growth | 2.85M 75.93% | 808.095K | 2.042M | 252.68% |
| Q3 2022 Q2Q % growth | 1.81M 56.03% | 758.197K | 1.052M | 138.72% |
| Q2 2022 Q2Q % growth | 2.37M 393.75% | 863.603K | 1.506M | 174.43% |
| Q1 2022 Q2Q % growth | 1.59M 318.42% | 834.697K | 755.303K | 90.49% |
| Q4 2021 Q2Q % growth | 1.62M | 441.997K | 1.178M | 266.52% |
| Q3 2021 Q2Q % growth | 1.16M | 135.997K | 1.024M | 752.96% |
| Q2 2021 Q2Q % growth | 480K | 204K | 276K | 135.29% |
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | 0% | 7.64% | 0% | 12.59% |
| Revenue | 0% | -6.66% | 0% | 250.89% |